Terminal node problems: ANT 2.0 and prescription drug labels

ABSTRACT This article examines prescription drug labels (PDLs) via an actor-network theory analysis to demonstrate current challenges with technical communication (TC) scholars’ appropriation of actor-network theory. The authors demonstrate that the complexity of the PDL network requires a more nuanced deployment of actor-network theory notions of durability and synchronicity. Specifically, the authors suggest that diachronic approaches to networks enable a more comprehensive understanding in ways that synchronic approaches cannot.

[1]  R. Miettinen,et al.  The riddle of things: Activity theory and actor‐network theory as approaches to studying innovations , 1999 .

[2]  Ross Koppel,et al.  Medication Safety in Older Adults: Home‐Based Practice Patterns , 2005, Journal of the American Geriatrics Society.

[3]  Dorothy Winsor.  Using Writing to Structure Agency: An Examination of Engineers' Practice , 2006 .

[4]  Huiling Ding,et al.  Transcultural Risk Communication and Viral Discourses: Grassroots Movements to Manage Global Risks of H1N1 Flu Pandemic , 2013 .

[5]  Ros Dowse,et al.  Medicine labels incorporating pictograms: do they influence understanding and adherence? , 2005, Patient education and counseling.

[6]  S. Scott Graham,et al.  Public Voices in Pharmaceutical Deliberations: Negotiating “Clinical Benefit” in the FDA’s Avastin Hearing , 2014, Journal of Medical Humanities.

[7]  D. Squires,et al.  The U.S. health system in perspective: a comparison of twelve industrialized nations. , 2011, Issue brief.

[8]  John Law,et al.  Notes on the theory of the actor-network: Ordering, strategy, and heterogeneity , 1992 .

[9]  S. Katz,et al.  ‘Aristotle's pharmacy’: The medical rhetoric of a clinical protocol in the drug development process , 2000 .

[10]  Laura M. Curtis,et al.  Effect of Standardized, Patient-Centered Label Instructions to Improve Comprehension of Prescription Drug Use , 2011, Medical care.

[11]  C. Herndl,et al.  Multiple Ontologies in Pain Management: Toward a Postplural Rhetoric of Science , 2013 .

[12]  M. Wolf,et al.  Misunderstanding of prescription drug warning labels among patients with low literacy. , 2006, American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists.

[13]  M. Wolf,et al.  To err is human: patient misinterpretations of prescription drug label instructions. , 2007, Patient education and counseling.

[14]  David R. Gruber.  Mirror Neurons in a Group Analysis “Hall of Mirrors”: Translation as a Rhetorical Approach to Neurodisciplinary Writing , 2014 .

[15]  K. K. Cetina,et al.  Unscrewing the big Leviathan: how actors macro- structure reality and how sociologists help them to do so , 2014 .

[16]  B. Latour.  Technology is Society Made Durable , 1990 .

[17]  Jennifer R. Webb,et al.  Patient-centered approach for improving prescription drug warning labels. , 2008, Patient education and counseling.

[18]  Gordon R. Mitchell,et al.  Translation Through Argumentation in Medical Research and Physician-Citizenship , 2012, The Journal of medical humanities.

[19]  B. Latour.  On actor-network theory : A few clarifications , 1996 .

[20]  J. Law.  After Ant: Complexity, Naming and Topology , 1999 .

[21]  B. Latour.  Science in action : how to follow scientists and engineers through society , 1989 .

[22]  Marcus Paroske,et al.  Overcoming Burdens of Proof in Science Regulation: Ephedra and the FDA , 2012, Rhetoric and Public Affairs.

[23]  Christa Teston.  Moving From Artifact to Action: A Grounded Investigation of Visual Displays of Evidence during Medical Deliberations , 2012 .

[24]  William H Shrank,et al.  A critical review of FDA-approved Medication Guides. , 2006, Patient education and counseling.

[25]  B. Latour.  Networks, Societies, Spheres: Reflections of an Actor-network Theorist , 2010 .

[26]  Jason Swarts,et al.  Recycled Writing: Assembling Actor Networks From Reusable Content , 2010 .

[27]  S. Graham.  Agency and the Rhetoric of Medicine: Biomedical Brain Scans and the Ontology of Fibromyalgia , 2009 .

[28]  S Scott Graham.  Dis-ease or Disease? Ontological Rarefaction in the Medical-Industrial Complex , 2011, The Journal of medical humanities.

[29]  Stacy Cooper Bailey,et al.  Improving prescription drug warnings to promote patient comprehension. , 2010, Archives of internal medicine.

[30]  Ashley R. Bergeron,et al.  Measuring patients' self-efficacy in understanding and using prescription medication. , 2010, Patient education and counseling.

[31]  E. Barton.  Discourse Methods and Critical Practice in Professional Communication , 2004 .

[32]  Clay Spinuzzi.  Who Killed Rex? Tracing a Message Through Three Kinds of Networks , 2007 .

[33]  J. Dumit.  Picturing Personhood: Brain Scans and Biomedical Identity , 2004 .

[34]  M. Wolf,et al.  Literacy and Misunderstanding Prescription Drug Labels , 2007, Annals of Internal Medicine.

[35]  Catherine F. Schryer,et al.  Genre Theory, Health-Care Discourse, and Professional Identity Formation , 2005 .

[36]  R. Kravitz,et al.  Physician communication when prescribing new medications. , 2006, Archives of internal medicine.

[37]  L. Sharp,et al.  From idea to market: the drug approval process. , 2001, The Journal of the American Board of Family Practice.

[38]  Miles A. Kimball,et al.  Visual Design Principles: An Empirical Study of Design Lore , 2013 .

[39]  P. Aspden,et al.  Preventing Medication Errors , 2007 .

[40]  C. Herndl,et al.  Talking Off-Label: The Role of Stasis in Transforming the Discursive Formation of Pain Science , 2011 .

[41]  James C. Wilson.  Making disability visible: How disability studies might transform the medical and science writing classroom , 2000 .

[42]  Tatiana Batova,et al.  Writing for the participants of international clinical trials: Law, ethics, and culture , 2010 .

[43]  Liza Potts,et al.  Contextualizing Experiences: Tracing the Relationships Between People and Technologies in the Social Web , 2011 .

[44]  B. Latour.  On Recalling Ant , 1999 .